Conducting clinical trials during the COVID-19 pandemic-a collaborative trial network response

Australasian Kidney Trials Network

Research output: Contribution to journalLetter

Abstract

The unprecedented demand placed on healthcare systems from the COVID-19 pandemic has forced a reassessment of clinical trial conduct and feasibility. Consequently, the Australasian Kidney Trials Network (AKTN), an established collaborative research group known for conducting investigator-initiated global clinical trials, had to efficiently respond and adapt to the changing landscape during COVID-19. Key priorities included ensuring patient and staff safety, trial integrity and network sustainability for the kidney care community. New resources have been developed to enable a structured review and contingency plan of trial activities during the pandemic and beyond.

Original languageEnglish
Number of pages1
JournalTrials
Volume22
Issue number1
DOIs
Publication statusPublished - 14 Apr 2021

Fingerprint Dive into the research topics of 'Conducting clinical trials during the COVID-19 pandemic-a collaborative trial network response'. Together they form a unique fingerprint.

Cite this